<DOC>
	<DOC>NCT01746004</DOC>
	<brief_summary>This study involves a single dose of 150 milligram (mg) of radiolabeled LY2157299 monohydrate in healthy participants. The study will determine how the body eliminates the radioactivity and LY2157299 monohydrate. Participants must be healthy surgically sterile or postmenopausal females, or sterile males. This study is approximately 8 to 15 days.</brief_summary>
	<brief_title>A Study of LY2157299 Monohydrate in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy surgically sterile females, postmenopausal females, or sterile males Body mass index (BMI) of 18.5 to 32.0 kilograms per square meter (kg/m^2) Have venous access sufficient to allow for blood sampling Have known allergies to LY2157299, related compounds or any components of the formulation Have an abnormal blood pressure as determined by the investigator Have participated in a [^14C]study within the last 6 months prior to admission for this study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>